GENUINE progress
TG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
Download this eBook from Drug Discovery News to learn about leading immunotherapy drugs in the pipeline and discover new approaches to immunotherapy drug discovery and delivery.
View eBookBacteria engineered to produce therapeutics fill a niche for patients with unmet medical needs.
View ArticleBiobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.
View Infographic